News

2025.01.16

Researchers aim to reveal mechanisms leading to schizophrenia

Researchers from University of Copenhagen, Karolinska Institute and University of Zurich join forces to close the knowledge gap on how schizophrenia develops.

New PI

2025.01.06

New BRIC-group leader: The beauty of this job is generating knowledge that cures people

Asking the right questions is crucial to conduct science that has an impact. Cristian Bellodi, Professor and new Group Leader at BRIC, strives to bridge fundamental research and innovation to make an impact.

EMBO Young Young Investigators:

2024.12.05

Eva Kummer Selected for Prestigious International Programme

EMBO announces new exceptional scientists, who represent innovation and excellence in their fields, to join the EMBO Young Investigators Programme. BRIC group leader Eva Kummer is selected.

Glioblastoma

2024.11.27

Researchers can now identify cancer cells leading to tumor recurrence

Cancer cells escaping tumors in the brain avoid surgery and create new recurrent tumors, but now researchers from the University of Copenhagen and Rigshospitalet have identified and characterized these cells. This can…

New programme:

2024.11.18

New interdisciplinary PhD programme supported by 6.6 million EURO Marie S. Curie grant

BRIC joins forces with physical science and engineering environments at University of Copenhagen and the Technical University of Denmark in establishing a new interdisciplinary PhD training programme, INTERACT. The PhDs…

Leadership:

2024.11.12

Postdocs to group leaders and institutes: This is how you cultivate the next generation of research leaders

What can postdocs, group leaders and research institutions do to cultivate better research leaders? Six postdocs publish a guide with their insights on leadership in training programs.

Knæk Cancer:

2024.11.01

BRIC researcher participates in prime-time TV-show to explain how fundamental research can help cancer patients

This year, Fena Ochs, is part of the “Knæk Cancer” fundraising show by the Danish Cancer Society and Danish TV-channel TV2. She shows how Knæk Cancer supports her research in breast- and ovarian cancer.

2024.10.28

Equipping researchers of today with communication tools to reach beyond academia

In collaboration, EU-LIFE and BRIC have developed a science communication training workshop, equipping researchers with tools to communicate their research to the world outside academia.

New PI

2024.10.04

New research group brings structural biology knowledge to BRIC

Eva Kummer is the new group leader at BRIC. She moves her lab, knowledge and technology from Center for Protein Research, CPR.

Down's syndrome

2024.09.26

Now we know why children with Down’s syndrome have higher risk of Leukemia

People with Down’s syndrome face a higher risk of developing Leukemia. Now researchers from the University of Copenhagen explain why, by identifying specific changes in blood cells of people with Down’s syndrome.

2024.07.08

Lars Engelholm awarded prestigious grant to advance innovative pan-cancer therapy

Patients suffering from pancreatic cancer, as well as other cancer types, may face better treatment in the future. Researchers from BRIC and Rigshospitalet are awarded a 5 million DKK Frontier Grant by LF.

Immunotherapy

2024.06.06

BRIC professor Janine Erler awarded Novo Nordisk Foundation Distinguished Innovator Grant

Professor Janine Erler receives a DKK 5,94 million grant to support the development of a new anticancer therapy for clinical applications. Her goal is to produce RNA-based therapies targeting metastatic tumor growth.

2023.12.19

PUBLICATION SPOTLIGHT – Are newly identified metabolic regulating molecules promising for T-cell immunotherapy?

Regulation of mitochondria respiration and metabolism, the powerhouse of all cells, is essential for anti-inflammatory FoxA1+ regulatory T cell generation.

2023.12.05

Medication in lower doses can save the healthcare system billions of DKK

The effect of cancer drugs can often be preserved even when the labeled dose is significantly reduced. This can be used to spare cancer patients from side effects, free up staffing resources, and save the Danish…

2023.11.16

Denmark funds BRIC cancer research projects

From left: Fena Ochs, Jesper Andersen, Niels Behrendt Thanks to the generous donations made during the 2023 Knæk Cancer show last month, run by Danish Cancer Society and TV2, BRIC researchers Fena Ochs, Niels Behrend…

2023.11.02

Group leader Joachim Weischenfeldt appointed professor

Group Leader Joachim Weischenfeldt has been appointed “Clinical professor in clinical oncology with special focus on cancer genetics and structural variations” on 1 November 2023. Weischenfeldt group is interested in…

2023.10.23

Mapping the evolution of the human genome – A Portrait of New Group Leader Fran Supek

Fran Supek, new Group Leader and Professor at the Biotech Research & Innovation Centre (BRIC) in Copenhagen aims to achieve a deeper understanding of the processes behind cancer mutations. He will do so by combining…

2023.10.09

PUBLICATION SPOTLIGHT – How a “good” leukemia turns “bad” and how we can turn it “good” again

By Anna S Wilhelmson, Senior Scientist, Porse Group How would you summarise your study in one sentence? Through a successful collaboration between the Porse lab here at the Finsen Laboratory and BRIC and the Grebien lab…

The brain

2023.10.05

Researchers find a cause of Parkinson’s disease

A significant breakthrough sheds light on the underlying mechanisms of Parkinson's disease, offering the potential for innovative treatments in the future.

2023.09.18

Turning the Right Cell-Switch to unlock the Cure for Cancer

All cells have thousands of switches on their surface, so-called ‘receptors'. Turning the right ones allows us to develop smart and more effective cures against cancer.

Ribosome

2023.09.12

Oldest known molecule surprises researchers. It could lead to new important treatments

Researchers have previously believed that the ribosome, one of the body's most crucial molecular machines, was merely a helper when creating new cells. However, recent research reveals that the ribosome has far greater…

2023.07.04

Group leader Konstantin Khodosevich appointed professor

Group Leader Konstantin Khodosevich has been appointed professor in neurodevelopmental disorders by July 1st 2023. Konstantin Khodosevich has been a group leader at BRIC since 2015. The goal of Khodosevich Group is to…

2023.06.26

Michael Ploug receives research grant to study the breakdown of fat in the smallest blood vessels

BRIC/Finsen Group Leader, Michael Ploug, and his Network Receives a Research Grant to Study the breakdown of fat in the smallest blood vessels.

2023.06.19

Group leaders Jesper B. Andersen and Claus S. Sørensen appointed professors

Group Leader Jesper B. Andersen has been appointed professor in translational hepatology by June 1st 2023. Jesper B. Andersen has been a group leader at BRIC since 2014. The goal of Andersen Group is to unravel the…

NEW GROUP LEADER

2023.06.07

Illuminating the Cellular World - A Portrait of New Group Leader Fena Ochs

Fena Ochs is new Group Leader and Associate Professor at the Biotech Research & Innovation Centre (BRIC) in Copenhagen.

2023.05.15

The iMED programme pushed the limits of PhD training at BRIC

On May 2nd BRIC hosted the ending symposium for the 2nd cohort of PhD fellows from the International Doctoral Program in Molecular Mechanisms of Disease (iMED). Since 2019, iMED enrolled 23 talented international PhD…

INNOVATION

2023.04.11

BRIC/Finsen spinout Adcendo Aps moves forward towards clinical trials

Closing a Series A extension financing of 31 million euro will allow BRIC/Finsen spinout Adcendo ApS to conduct broad phase 1 testing of their uPARAP ADC, starting by the end of 2024.

FUNDING

2023.01.23

Professor Ana Cvejic receives a grant to better understand the interplay between immune cells and cancer

Ana Cvejic, a professor at Biotech Research & Innovation Centre (BRIC), was awarded the DNRF Chair Grant of 10 million DKK over a period of three years to gain knowledge about the interaction of immune and tumor cells.

INNOVATION

2023.01.05

Niels Behrendt receives the NNF Distinguished Innovator Grant

Niels Behrendt, group leader at the Finsen Laboratory, Rigshospitalet/BRIC receives the NNF Distinguished Innovator grant for a project focused on creating test ADC therapeutics.

Breast cancer

2022.12.06

New gene technology is able to predict the effect of treatment on the individual breast cancer patient

How do you know whether breast cancer treatment will be able to cure the individual patient? New gene technology can tell us, and it may prove vital to patients.

DISEASE

2022.10.20

Huge unveiling of schizophrenia brain cells show new treatment targets

For the first time, researchers show how schizophrenia affects both the single cell and regional cell networks in the brain. The study may provide new options for treating the disease.

2022.10.13

Translational AML trial improves clinical outcome and identifies novel drugs for future treatment

The LD-VenEx trial exemplifies the vast potential of clinical trials integrating translational research programs, says research group leader Kim Theilgaard-Mönch. In a large investigator-initiated trial, clinicians form…

2022.09.06

CellX Infrastructure Network strengthens single cell omics in Denmark and at BRIC

The Danish Ministry of Higher Education and Science has granted now DKK 51 million to the ‘CellX’ project, which aims to provide researchers across Denmark with better access to the analysis of cells and tissues at…

CRISPR

2022.08.19

New gene technology can reveal how well medicine works. Behind it, you will find the new company BioPhenyx

Researchers from the University of Copenhagen have started a new company which, on the basis of gene technology, shall make the development of medicine faster and more precise. According to the researchers behind the…

Cancer

2022.07.14

The immune system can help us diagnose cancer

How do you detect a dangerous cancer if you do not know exactly what to look for or where? New research into biliary tract cancer conducted at the University of Copenhagen can pave the way for early detection of the…

2022.06.27

Two BRIC researchers start their own research groups

Chiraq Nepal from Andersen Group and Diego García González from Khodosevich group have both received funding to start their own research groups outside the University of Copenhagen.

2022.05.02

Jesper B Andersen receives NNF Hallas-Møller Ascending Investigator grant

For 15 years, Jesper B Andersen has investigated the molecular pathogenesis of liver and bile duct cancers. Whereas, viral hepatitis is known to pose an increased risk for developing liver cancer for infected carriers,…

Cancer

2022.04.28

Research discovery reveals how a cancer cell resists radiation treatment

Radiation is usually an effective treatment for cancer. Unfortunately, cancer cells are frequently able to defend themselves against the treatment. But now researchers from the University of Copenhagen have shown how…

2022.04.06

Postdocs receive the prestigious Marie Skłodowska-Curie postdoctoral fellowship!

Congratulations to Lidia Moyano Galceran (Wennerberg group) and Kadi Lõhmussaar (Jensen group) who have received the prestigious Marie Skłodowska-Curie postdoctoral fellowship. This year, in the first round of the MSCA…

2022.03.31

Bringing genomics into the classroom of Danish high schools

In 2020, the Danish teaching material for high school students “Data analysis & Cancer (Dataanalyse & Kræft”) was launched, and since then, the material has received significant attention from teachers across Denmark.

2022.03.31

Leadership and management skills workshop

In the beginning of March, a Leadership and Management skills workshop took place at BRIC. The workshop was hosted by Hfp Consulting and ran over 3 days. The main goal was to enable young and senior scientists to master…

2022.03.23

ERC Consolidator grant for Dr. Ana Cvejic

Among the winners of the European Research Council’s latest round of Consolidator Grants are Dr. Ana Cvejic who has been awarded funding for her project Aneuploidy and Its Impact on Blood Development: Context Matters.…

2022.03.18

Escape room at BRIC!

On 15 march 2022, during the brain awareness week, BRIC scientists locked up 30 high-school students within the research centre – To escape, the students had to find a (fictional) cure for Parkinson’s disease! Din…

Ulcerative colitis

2022.03.11

Quantum leap towards transplanting stem cells into the intestines

Stem cell transplantation can cure mice suffering from inflammation in the large intestine. This is good news for ulcerative colitis patients, as it may lead to the development of new treatment forms that do not result…

2022.02.11

BRIC celebrates the International Day of Women & Girls in Science

On Friday 11th of February BRIC marks the International Day of Women and Girls in Science by hosting an internal panel discussion with six successful female alumni from academia and industry. The BRIC Diversity &…

2022.02.04

New Head of the MoMeD Programme

From January 1st 2022 Professor Shohreh Issazadeh-Navikas has been appointed new head of the MoMeD PhD Programme. Shohreh takes over from Kim Jensen, who has from January 1st moved his research group to the new Novo…

2022.01.10

BRIC welcomes new group leader Ana Cvejic

The Novo Nordisk Foundation has awarded Dr. Ana Cvejic a Young Investigator Award to set up a research group at BRIC in 2022 where she will study the molecular mechanisms involved in the development of blood cells. The…

2021.11.25

New disease model puts metastasis in a box

Cancer cells can travel away from the tumour where they originate and establish distant colonies (a process known as metastasis). Metastatic tumours are extremely difficult to treat and remain responsible for most cance…

Cancer

2021.11.23

Molecular hijacking: Cancer gene re-programs ‘protein factories’ to stimulate cell growth

The ribosomes, the ‘protein factories’ in our cells, can be altered by cancer genes, a new study from the University of Copenhagen shows. This has implications for our understanding of both normal development and…

Genetics

2021.11.03

Researchers identify gene heavily linked to psychiatric disease

Advanced algorithms and functional animal studies have revealed a new gene linked to psychiatric disease.

Pandemic

2021.10.18

New COVID-19-discovery could predict patient death or hospitalization

In a new study, researchers from University of Copenhagen shows that the phenomenon cell fitness could predict the host immune response to a COVID-19-infection.

Drugs

2021.10.08

Frontrunner target for Parkinson’s Disease may only be relevant for small fraction of patients

The industry are developing drugs for Parkinson’s Disease aimed at a specific mechanism. But they may not help the majority of patients suffering from the disease, new mouse study from University of Copenhagen suggests.

2021.07.08

PUBLICATION SPOTLIGHT - PIAS2-mediated blockade of IFN-β signaling: A basis for sporadic Parkinson disease dementia

By Emilie Tresse-Gommeaux, Assistant Professor, Issazadeh-Navikas Group How would you summarise your research into one sentence? Our work clearly demonstrates that dysregulation of the immune genes in the brain is a…

2021.06.18

Promising study on the immune system in pancreatic cancer

New study by Erler group explores the immune system’s function in pancreatic cancer and finds that an existing therapy can be used to suppress pancreatic tumor development in pre-clinical mouse models. The research was…

2021.06.07

PUBLICATION SPOTLIGHT - Single cell proteomics detects heterogeneity in complex cell systems

By Benjamin Furtwängler, PhD fellow, Porse Group How would you summarise your study in one sentence? We present a comprehensive mass spectrometry-based single-cell proteomics workflow that enables the characterization o…

2021.04.27

PUBLICATION SPOTLIGHT - The long non-coding RNA MIR31HG regulates the senescence associated secretory phenotype

By Marta Montes Resano, Assistant professor, Lund Group How would you summarise your study in one sentence? The long non-coding RNA (lncRNA) MIR31HG regulates the expression and secretion of a subset of components from…

CANCER

2021.02.11

FEATURE - Unraveling the mysteries of a rare cancer

Group Leader Jesper B Andersen from BRIC is one of the researchers behind the initiative World Cholangiocarcinoma Day - an international effort to raise awareness of the rare and highly aggressive cancer of the bile…

2021.01.25

New scientific discovery may enable accurate prediction of cancer spread even before cancer develops

Researchers from Erler Group at the Biotech Research & Innovation Centre (BRIC) in Copenhagen have discovered that the rigidity of a thin membrane structure encompassing cells and lining all vessels regulates how easily…

2020.12.04

Tumor microenvironment could play an important role in gallbladder carcinogenesis

A new study from the Andersen Group, BRIC at University of Copenhagen and researchers at the Division of Cancer Epidemiology and Genetics (DCEG), National Cancer Institute, part of the National Institutes of Health in…

Precision medicine

2020.09.15

Biomarker reveals how aggressive biliary tract cancer is in patients

PRECISION MEDICINE Researchers from University of Copenhagen and Herlev and Gentofte Hospital have discovered a biomarker that might predict the course of the disease in patients with biliary tract cancer (BTC). The…

2020.08.04

BRIC researchers discover role of metabolism gene in brain dysfunction

Researchers from Khodosevich group at BRIC and Perrier’s group at Department of Neuroscience have discovered that the function of neurons most affected by mental disorders are dependent of a specific molecule. This…

2020.07.03

New method reveals common biomarker for cancer and neurodegeneration disease

A new and more precise method of sequencing mitochondrial DNA developed by researchers from Issazadeh-Navikas Group at BRIC has revealed a mutation hotspot which is associated with both neurodegeneration disease and…

2020.06.30

Reducing ADAM12 protein can limit activation of overly active immune cells in MS

INFLAMMATORY DISEASE In a new study, researchers from the Issazadeh-Navikas group, BRIC, show that the protein ADAM12 plays an essential role in the function of immune cells and that reducing the protein can limit the…

2020.05.22

Researchers Discover How Protein Can Inhibit Cancer Development in Mice

In a new study, researchers from the University of Copenhagen have discovered how the protein PP2A can inhibit tumour growth in mice. The protein turns off an enzyme that stimulates cell growth, thus inhibiting the…

Cancer

2020.05.14

Danish Researchers Find New Breast Cancer Gene in Young People

New research shows for the first time that RBBP8 gene variants may lead to the development of breast cancer in very young women.

Personalized medicine

2020.02.10

PTH - Towards personalized medicine

With a significant grant from the Novo Nordisk Foundation awarded in 2017 to start the DanStem-affiliated PTH program, Professors Kirsten Grønbæk from the Department of Hematology (Rigshospitalet), Bo Porse from the…

Cancer mutations

2020.02.05

Global study maps cancer mutations in large catalogue

Mutations in 38 different types of cancer have been mapped by means of whole genome analysis by an international team of researchers from, amongst others, the University of Copenhagen, Aarhus University, Aarhus…

2019.12.17

Ancient worm reveals way to destroy toxic cells in Huntington’s disease

Researchers from Monash Biomedicine Discovery Institute (BDI), Univeristy of Cambridge and University of Copenhagen, have identified a highly conserved mechanism in worms and humans that controls the removal of toxic…

Pregnancy

2019.10.30

How are psychiatric disorders linked to infections during pregnancy?

Severe infections during pregnancy have been connected to a range of psychiatric disorders by different studies in humans and animals. Now, researchers from the University of Copenhagen have shown in mice how the…

2019.10.15

Novel insight into PRMT5, a promising therapeutic target for cancer treatment

Despite progress in the treatment of patients with cancer, it is still a devastating disease with an urgent need for more precise and effective medicine. This requires a better understanding of the mechanism leading to…

Genetics

2019.09.20

New insight as to how cells maintain their identity

In the body's cells, some proteins are of vital importance as to which genes are active or turned off. Now, researchers from the University of Copenhagen and the Memorial Sloan Kettering Cancer Center have discovered…

Stem Cells

2019.07.30

Stem Cell Research Sheds New Light on the Skin

For the first time, researchers from the University of Copenhagen have studied and outlined the development of sebaceous glands in the skin. The study provides greater insight into the development and maintenance of the…

2019.07.09

Study points to CD73 as novel therapeutic target in acute myeloid leukemia

A recent study from the Porse group at the Finsen Laboratory, DanStem and BRIC, shows that the cancer-protective and -targetable CD73-gene is upregulated in a type of leukemia, indicating a potential novel therapy. …

2019.05.22

Transcription Re-Orders the Epigenome after DNA Replication

Published in Molecular Cell, a study from the Groth laboratory at the Biotech Research and Innovation Centre, University of Copenhagen, shows that transcription, the first step in the process by which genes are…

2019.05.16

Surprising Research Result: All Immature Cells Can Develop into Stem Cells

New sensational study conducted at the University of Copenhagen disproves traditional knowledge of stem cell development. The study reveals that the destiny of intestinal cells is not predetermined, but instead…

Stem cells

2019.04.05

Mutation Stands in the Way of Healthy Blood Cell Maturation

In a new study, researchers from the University of Copenhagen and EMBL in Heidelberg have learned how a specific genetic mutation affects the maturation of blood cells in mouse models. Leukaemia patients often have a…

DNA

2019.02.25

Researchers Discover ’Chromosome Scanner’ that Protects Against Cancer

In a new study, researchers from the University of Copenhagen have identified one of the main mechanisms behind the repair of serious damage to the human DNA. A ‘scanner’ inside the cells decides whether or not so-calle…

Biotech Research & Innovation Centre

Researchers aim to reveal mechanisms leading to schizophrenia

New BRIC-group leader: The beauty of this job is generating knowledge that cures people

Eva Kummer Selected for Prestigious International Programme

Researchers can now identify cancer cells leading to tumor recurrence

New interdisciplinary PhD programme supported by 6.6 million EURO Marie S. Curie grant

Postdocs to group leaders and institutes: This is how you cultivate the next generation of research leaders

BRIC researcher participates in prime-time TV-show to explain how fundamental research can help cancer patients

Equipping researchers of today with communication tools to reach beyond academia

New research group brings structural biology knowledge to BRIC

Now we know why children with Down’s syndrome have higher risk of Leukemia

Lars Engelholm awarded prestigious grant to advance innovative pan-cancer therapy

Now we know why successful treatment does not affect specific cancer cells

New BRIC group leader seeks a multi-expertise approach in research

Secrets of cell division revealed by cutting-edge imaging technique

BRIC Pioneers Advanced Imaging Technology in Denmark

BRIC is hiring one or two new group leaders

BRIC professor Janine Erler awarded Novo Nordisk Foundation Distinguished Innovator Grant

PUBLICATION SPOTLIGHT – Are newly identified metabolic regulating molecules promising for T-cell immunotherapy?

Medication in lower doses can save the healthcare system billions of DKK

Denmark funds BRIC cancer research projects

Group leader Joachim Weischenfeldt appointed professor

Mapping the evolution of the human genome – A Portrait of New Group Leader Fran Supek

PUBLICATION SPOTLIGHT – How a “good” leukemia turns “bad” and how we can turn it “good” again

Researchers find a cause of Parkinson’s disease

Turning the Right Cell-Switch to unlock the Cure for Cancer

Oldest known molecule surprises researchers. It could lead to new important treatments

Group leader Konstantin Khodosevich appointed professor

Michael Ploug receives research grant to study the breakdown of fat in the smallest blood vessels

Group leaders Jesper B. Andersen and Claus S. Sørensen appointed professors

Illuminating the Cellular World - A Portrait of New Group Leader Fena Ochs

The iMED programme pushed the limits of PhD training at BRIC

BRIC/Finsen spinout Adcendo Aps moves forward towards clinical trials

Professor Ana Cvejic receives a grant to better understand the interplay between immune cells and cancer

Niels Behrendt receives the NNF Distinguished Innovator Grant

New gene technology is able to predict the effect of treatment on the individual breast cancer patient

Huge unveiling of schizophrenia brain cells show new treatment targets

Translational AML trial improves clinical outcome and identifies novel drugs for future treatment

CellX Infrastructure Network strengthens single cell omics in Denmark and at BRIC

New gene technology can reveal how well medicine works. Behind it, you will find the new company BioPhenyx

The immune system can help us diagnose cancer

Two BRIC researchers start their own research groups

Jesper B Andersen receives NNF Hallas-Møller Ascending Investigator grant

Research discovery reveals how a cancer cell resists radiation treatment

Postdocs receive the prestigious Marie Skłodowska-Curie postdoctoral fellowship!

Bringing genomics into the classroom of Danish high schools

Leadership and management skills workshop

ERC Consolidator grant for Dr. Ana Cvejic

Escape room at BRIC!

Quantum leap towards transplanting stem cells into the intestines

BRIC celebrates the International Day of Women & Girls in Science

New Head of the MoMeD Programme

BRIC welcomes new group leader Ana Cvejic

New disease model puts metastasis in a box

Molecular hijacking: Cancer gene re-programs ‘protein factories’ to stimulate cell growth

Researchers identify gene heavily linked to psychiatric disease

New COVID-19-discovery could predict patient death or hospitalization

Frontrunner target for Parkinson’s Disease may only be relevant for small fraction of patients

PUBLICATION SPOTLIGHT - PIAS2-mediated blockade of IFN-β signaling: A basis for sporadic Parkinson disease dementia

Promising study on the immune system in pancreatic cancer

PUBLICATION SPOTLIGHT - Single cell proteomics detects heterogeneity in complex cell systems

PUBLICATION SPOTLIGHT - The long non-coding RNA MIR31HG regulates the senescence associated secretory phenotype

FEATURE - Unraveling the mysteries of a rare cancer

New scientific discovery may enable accurate prediction of cancer spread even before cancer develops

Tumor microenvironment could play an important role in gallbladder carcinogenesis

Biomarker reveals how aggressive biliary tract cancer is in patients

BRIC researchers discover role of metabolism gene in brain dysfunction

New method reveals common biomarker for cancer and neurodegeneration disease

Reducing ADAM12 protein can limit activation of overly active immune cells in MS

Researchers Discover How Protein Can Inhibit Cancer Development in Mice

Danish Researchers Find New Breast Cancer Gene in Young People

PTH - Towards personalized medicine

Global study maps cancer mutations in large catalogue

Ancient worm reveals way to destroy toxic cells in Huntington’s disease

How are psychiatric disorders linked to infections during pregnancy?

Novel insight into PRMT5, a promising therapeutic target for cancer treatment

New insight as to how cells maintain their identity

Stem Cell Research Sheds New Light on the Skin

Study points to CD73 as novel therapeutic target in acute myeloid leukemia